Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 43 of 43 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AgBiome Inc. | Activity: Research and Development | Company Description AgBiome uses its proprietary GENESIS™ platform to capture diverse, unique microbes for agriculturally relevant applications, and screens them with industry-best assays for insect, disease, and nematode control. AgBiome also develops and sells crop protection solutions. | Location Research Triangle Park |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company BASF Agricultural Solutions (RTP) | Activity: Research and Development | Company Description BASF's Agricultural Solutions division conducts seeds, traits and plant biotechnology research with a focus on yield and quality traits in major crops. Its RTP campus also houses a bee care center. | Location Research Triangle Park |
| |
Company CasTag Biosciences Inc. | Activity: Production and Manufacturing | Company Description CasTag Biosciences provides custom AAV kits. It uses CRISPR knock-in technology to produce genome-wide arrayed libraries with a variety of donors for endogenous protein analysis in cells and tissue. | Location Durham |
| |
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |
| |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |
| |
Company Cotton Incorporated | Activity: Research and Development | Company Description Cotton Incorporated's Agricultural & Environmental Research Division improves cotton cultivation through genetic and biotechnology tools, enhancing yield, quality and resistance of cotton varieties. | Location Cary |
| |
||||
| |
Company Envu | Activity: Research and Development | Company Description Envu develops and markets pest-, weed- and disease-control products for non-agricultural areas such as vector control, professional pest management, industrial vegetation management, forestry and turf and ornamentals. | Location Cary |
| |
Company Gene Master LLC | Activity: Contract Research and Testing | Company Description Gene Master provides contract biomedical research services such as genotyping and vector construction. Gene Master helps design and perform biological experiments. | Location Cary |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company Innatrix Inc. | Activity: Research and Development | Company Description Innatrix is developing eco-friendly alternative means of crop protection, utilizing a patented peptide & RNAi delivery technology platform. | Location Research Triangle Park |
| |
Company Life Edit Therapeutics | Activity: Research and Development | Company Description Life Edit Therapeutics, an ElevateBio company, identifies novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships. | Location Durham |
| |
Company Locus Biosciences Inc. | Activity: Research and Development | Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed. | Location Morrisville |
| |
Company Pairwise | Activity: Research and Development | Company Description Pairwise develops new varieties of crops by developing genome editing tools, leveraging plants' natural genetic diversity, and creating partnerships and collaborations with agriculture companies. | Location Durham |
| |
Company Pfizer Inc. (Durham) | Activity: Research and Development | Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. | Location Durham |
| |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage gene editing company using its novel ARCUS genome editing platform to develop new treatment options for cancer and genetic diseases. | Location Durham |
| |
Company Tavros Therapeutics Inc. | Activity: Research and Development | Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. | Location Research Triangle Park |
| |
Company TransViragen Inc. | Activity: Contract Research and Testing | Company Description TransViragen provides in vivo discovery research services, including the generation and analysis of genetically modified rodents and cell lines. | Location Chapel Hill |
| |
Company TreeCo | Activity: Research and Development | Company Description TreeCo is using CRISPR technology, combining tree genetics with genome editing, to enhance trees for the forestry industry and the environment. | Location Raleigh |
| |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham |